SCHEMBL33377934

SCHEMBL33377934

CC(C)c1cnn2c(Nc3ccncn3)cc(Cl)nc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 16/20 0.43
▸ CCNA2 P20248 5/20 0.43
▸ CCNA1 P78396 5/20 0.43
▸ GSK3B P49841 3/20 0.40
▸ CDK7 P50613 7/20 0.38
▸ CDK5 Q00535 7/20 0.36
▸ CDK5R1 Q15078 5/20 0.36
▸ DYRK1A Q13627 5/20 0.36
▸ CDK9 P50750 3/20 0.36
▸ CDK1 P06493 3/20 0.36
▸ CCNE1 P24864 3/20 0.36
▸ CCNH P51946 3/20 0.36
▸ CCNT1 O60563 2/20 0.36
▸ CDK4 P11802 2/20 0.36
▸ CCNB1 P14635 2/20 0.36
▸ CCND1 P24385 2/20 0.36
▸ CDK8 P49336 2/20 0.36
▸ CDK6 Q00534 2/20 0.36
▸ MNAT1 P51948 2/20 0.36
▸ INSRR P14616 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL33377988 0.85 CDK2 (0.42) CDK2CCNA2CCNA1GSK3BCDK7
SCHEMBL33378031 0.84 CDK7 (0.54) CDK2CCNA2CCNA1GSK3BCDK7
SCHEMBL33377883 0.84 CDK2 (0.43) CDK2CCNA2CCNA1GSK3BCDK7
SCHEMBL33378019 0.81 CDK2 (0.42) CDK2GSK3BCDK7CDK5CDK5R1
SCHEMBL33377919 0.80 CDK2 (0.41) CDK2GSK3BCDK7CDK5CDK5R1
SCHEMBL33378032 0.80 CDK2 (0.41) CDK2GSK3BCDK7CDK5CDK5R1
SCHEMBL33377983 0.80 CDK2 (0.43) CDK2CCNA2CCNA1GSK3BCDK7
SCHEMBL33378035 0.80 CDK2 (0.40) CDK2GSK3BCDK7CDK5CDK5R1
SCHEMBL33378033 0.79 CYP17A1 (0.36) CDK2CCNA2CCNA1GSK3BCDK5
SCHEMBL33377976 0.78 CDK2 (0.42) CDK2CCNA2CCNA1GSK3BCDK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4717312-A1 PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES USEFUL AS A MEDICAMENT Perha Pharmaceuticals (FR) 2026-04-01 — — EP disclosed
Send feedback